Samrat Pharmachem standalone net profit rises 348.08% in the March 2022 quarter

30 May 2022 , 05:57 PM

Net profit of Samrat Pharmachem rose 348.08% to Rs 6.99 crore in the quarter ended March 2022 as against Rs 1.56 crore during the previous quarter ended March 2021. Sales rose 26.89% to Rs 60.16 crore in the quarter ended March 2022 as against Rs 47.41 crore during the previous quarter ended March 2021. For the full year,net profit rose 222.33% to Rs 17.18 crore in the year ended March 2022 as against Rs 5.33 crore during the previous year ended March 2021. Sales rose 23.90% to Rs 221.81 crore in the year ended March 2022 as against Rs 179.02 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	60.16	47.41	27	221.81	179.02	24
OPM %	16.89	4.09	–	10.97	4.84	–
PBDT	10.08	2.09	382	24.21	7.85	208
PBT	9.93	1.96	407	23.62	7.36	221
NP	6.99	1.56	348	17.18	5.33	222

Powered by Capital Market – Live News